Literature DB >> 10344601

Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treated mice.

E J Talavera1, J L Arcaya, D Giraldoth, J Suárez, E Bonilla.   

Abstract

In the present study, we have evaluated whether melatonin (MEL) modulates Mn-induced decrease in spontaneous motor activity (SMA) and lipid peroxidation, estimated as malondialdehyde (MDA) formation, in several brain regions. In mice treated with manganese a decrease in SMA after 2 weeks of treatment was observed. In the group treated with Mn+MEL a significant greater reduction in SMA was detected at 4 weeks. MDA levels were reduced in both MEL and Mn treated mice. In the animals treated with MEL + Mn a higher reduction in MDA levels was observed. These results suggest that MEL modulates the effect of Mn on SMA and brain lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344601     DOI: 10.1023/a:1021064711866

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Short-term oral administration of several manganese compounds in mice: physiological and behavioral alterations caused by different forms of manganese.

Authors:  J Komura; M Sakamoto
Journal:  Bull Environ Contam Toxicol       Date:  1991-06       Impact factor: 2.151

2.  Alteration in some membrane properties in rat brain following exposure to manganese.

Authors:  R Kumar; S Srivastava; A K Agrawal; P K Seth
Journal:  Pharmacol Toxicol       Date:  1996-07

3.  Manganese and catecholamines.

Authors:  G C Cotzias; P S Papavasiliou; I Mena; L C Tang; S T Miller
Journal:  Adv Neurol       Date:  1974

Review 4.  The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders.

Authors:  J Donaldson
Journal:  Neurotoxicology       Date:  1987       Impact factor: 4.294

5.  Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  P Rojas; C Ríos
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

6.  Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes.

Authors:  I Antolín; C Rodríguez; R M Saínz; J C Mayo; H Uría; M L Kotler; M J Rodríguez-Colunga; D Tolivia; A Menéndez-Peláez
Journal:  FASEB J       Date:  1996-06       Impact factor: 5.191

7.  Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.

Authors:  I Sziráki; K P Mohanakumar; P Rauhala; H G Kim; K J Yeh; C C Chiueh
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

8.  Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats.

Authors:  J I Chuang; M T Lin
Journal:  J Pineal Res       Date:  1994-08       Impact factor: 13.007

9.  Melatonin stimulates brain glutathione peroxidase activity.

Authors:  L R Barlow-Walden; R J Reiter; M Abe; M Pablos; A Menendez-Pelaez; L D Chen; B Poeggeler
Journal:  Neurochem Int       Date:  1995-05       Impact factor: 3.921

10.  The role of dietary copper, manganese, selenium, and vitamin E in lipid peroxidation in tissues of the rat.

Authors:  D I Paynter
Journal:  Biol Trace Elem Res       Date:  1980-06       Impact factor: 3.738

View more
  3 in total

1.  Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water.

Authors:  Saritha Krishna; Celia A Dodd; Shahryar K Hekmatyar; Nikolay M Filipov
Journal:  Arch Toxicol       Date:  2013-07-06       Impact factor: 5.153

Review 2.  Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.

Authors:  Jerome A Roth
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

3.  Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes.

Authors:  S A McDougall; C M Reichel; C M Farley; M M Flesher; T Der-Ghazarian; A M Cortez; J J Wacan; C E Martinez; F A Varela; A E Butt; C A Crawford
Journal:  Neuroscience       Date:  2008-04-07       Impact factor: 3.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.